Prognosis
Moderna Files for Clearance of Covid Vaccine in Adolescents
This article is for subscribers only.
Moderna Inc. filed for U.S. emergency-use authorization of its Covid-19 vaccine in adolescents, a move that would further expand access to the pandemic preventive.
Authorization by the U.S. Food and Drug Administration would make it the second vaccine approved for this age group. Pfizer Inc. and partner BioNTech SE received authorization for use of their shot in teens in May. Both vaccines are now being studied in younger children.